Vertex Pharmaceuticals
VRTX
#175
Rank
A$175.81 B
Marketcap
A$685.73
Share price
-0.41%
Change (1 day)
-3.83%
Change (1 year)

Vertex Pharmaceuticals (VRTX) - Total assets

Total assets on the balance sheet as of September 2025 : A$37.43 Billion

According to Vertex Pharmaceuticals's latest financial reports the company's total assets are A$37.43 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Vertex Pharmaceuticals - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31A$36.22 B8.58%
2023-12-31A$33.36 B25.08%
2022-12-31A$26.67 B43.96%
2021-12-31A$18.52 B21.23%
2020-12-31A$15.28 B28.64%
2019-12-31A$11.88 B34.01%
2018-12-31A$8.86 B95.2%
2017-12-31A$4.54 B13.02%
2016-12-31A$4.01 B17.17%
2015-12-31A$3.42 B20.23%
2014-12-31A$2.85 B9.73%
2013-12-31A$2.59 B-2.08%
2012-12-31A$2.65 B23.51%
2011-12-31A$2.14 B26.56%
2010-12-31A$1.69 B-21.97%
2009-12-31A$2.17 B56.64%
2008-12-31A$1.38 B102%
2007-12-31A$0.68 B-41.15%
2006-12-31A$1.16 B55.81%
2005-12-31A$0.75 B6.45%
2004-12-31A$0.70 B-27.68%
2003-12-31A$0.97 B-32.69%
2002-12-31A$1.44 B-20.13%
2001-12-31A$1.81 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Gilead Sciences
GILD
A$88.12 B 135.43%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$201.58 B 438.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$195.03 B 421.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$145.86 B 289.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$290.28 B 675.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
A$0.45 B-98.79%๐Ÿ‡บ๐Ÿ‡ธ USA